APO Research
Talk to an analyst

APO RESEARCH · REPORT

Measle Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Measle Vaccine Market Analysis and Forecast 2026-2032

26 December 2025191 pages

Choose your research edition.

Industry ResearchMeasle Vaccine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Measle Vaccine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Measle Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Measle Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Measle Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Measle Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Measle Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Measle Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Measle Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Measle Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Measle Vaccine include Merck, McKesson Medical and Biovac, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Measle Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Measle Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Measle Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Measle Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Measle Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Measle Vaccine sales, projected growth trends, production technology, application and end-user industry.

Measle Vaccine Segment by Company

Merck

McKesson Medical

Biovac

Measle Vaccine Segment by Type

Inactivated Vaccine

Attenuated Vaccine

Measle Vaccine Segment by Application

Hospital

Scientific Research

Others

Measle Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Measle Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Measle Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Measle Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Measle Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Measle Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Measle Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Measle Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inactivated Vaccine Major Manufacturers Table 3. Attenuated Vaccine Major Manufacturers Table 4. Global Measle Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Scientific Research Major Manufacturers Table 7. Others Major Manufacturers Table 8. Measle Vaccine Industry Trends Table 9. Measle Vaccine Industry Drivers Table 10. Measle Vaccine Industry Opportunities and Challenges Table 11. Measle Vaccine Industry Restraints Table 12. Global Measle Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Measle Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Measle Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Measle Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Measle Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Measle Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Measle Vaccine Sales by Region (2021-2026) & (K Units) Table 19. Global Measle Vaccine Sales by Region (2027-2032) & (K Units) Table 20. Global Measle Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Measle Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Measle Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Measle Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Measle Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Measle Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Measle Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Measle Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Measle Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Measle Vaccine Manufacturers, Product Type & Application Table 30. Global Measle Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Measle Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Measle Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Measle Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Measle Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Measle Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Measle Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Measle Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Measle Vaccine Sales by Type (2021-2026) & (K Units) Table 40. Global Measle Vaccine Sales by Type (2027-2032) & (K Units) Table 41. Global Measle Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Measle Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Measle Vaccine Price by Type (2021-2026) & (US$/Unit) Table 44. Global Measle Vaccine Price by Type (2027-2032) & (US$/Unit) Table 45. Global Measle Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Measle Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Measle Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Measle Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Measle Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Measle Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Measle Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Measle Vaccine Sales by Application (2027-2032) & (K Units) Table 53. Global Measle Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Measle Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Measle Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Measle Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. Merck Company Information Table 58. Merck Business Overview Table 59. Merck Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Merck Measle Vaccine Product Portfolio Table 61. Merck Recent Development Table 62. McKesson Medical Company Information Table 63. McKesson Medical Business Overview Table 64. McKesson Medical Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. McKesson Medical Measle Vaccine Product Portfolio Table 66. McKesson Medical Recent Development Table 67. Biovac Company Information Table 68. Biovac Business Overview Table 69. Biovac Measle Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Biovac Measle Vaccine Product Portfolio Table 71. Biovac Recent Development Table 72. North America Measle Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Measle Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Measle Vaccine Sales by Type (2021-2026) & (K Units) Table 75. North America Measle Vaccine Sales by Type (2027-2032) & (K Units) Table 76. North America Measle Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Measle Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Measle Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Measle Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Measle Vaccine Sales by Application (2021-2026) & (K Units) Table 81. North America Measle Vaccine Sales by Application (2027-2032) & (K Units) Table 82. North America Measle Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Measle Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Measle Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Measle Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Measle Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Measle Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Measle Vaccine Sales by Country (2021-2026) & (K Units) Table 89. North America Measle Vaccine Sales by Country (2027-2032) & (K Units) Table 90. North America Measle Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Measle Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 93. Canada Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 94. Mexico Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 95. Europe Measle Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Measle Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Measle Vaccine Sales by Type (2021-2026) & (K Units) Table 98. Europe Measle Vaccine Sales by Type (2027-2032) & (K Units) Table 99. Europe Measle Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe Measle Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe Measle Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Measle Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Measle Vaccine Sales by Application (2021-2026) & (K Units) Table 104. Europe Measle Vaccine Sales by Application (2027-2032) & (K Units) Table 105. Europe Measle Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe Measle Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe Measle Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Measle Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Measle Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Measle Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe Measle Vaccine Sales by Country (2021-2026) & (K Units) Table 112. Europe Measle Vaccine Sales by Country (2027-2032) & (K Units) Table 113. Europe Measle Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe Measle Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 116. France Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 117. U.K. Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 118. Italy Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 119. Russia Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 120. Spain Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 123. Sweden Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 124. Poland Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 125. China Measle Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 126. China Measle Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 127. China Measle Vaccine Sales by Type (2021-2026) & (K Units) Table 128. China Measle Vaccine Sales by Type (2027-2032) & (K Units) Table 129. China Measle Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China Measle Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China Measle Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 132. China Measle Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 133. China Measle Vaccine Sales by Application (2021-2026) & (K Units) Table 134. China Measle Vaccine Sales by Application (2027-2032) & (K Units) Table 135. China Measle Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China Measle Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Measle Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Measle Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Measle Vaccine Sales by Type (2021-2026) & (K Units) Table 140. Asia Measle Vaccine Sales by Type (2027-2032) & (K Units) Table 141. Asia Measle Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia Measle Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia Measle Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Measle Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Measle Vaccine Sales by Application (2021-2026) & (K Units) Table 146. Asia Measle Vaccine Sales by Application (2027-2032) & (K Units) Table 147. Asia Measle Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia Measle Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Measle Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Measle Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Measle Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Measle Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia Measle Vaccine Sales by Country (2021-2026) & (K Units) Table 154. Asia Measle Vaccine Sales by Country (2027-2032) & (K Units) Table 155. Asia Measle Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia Measle Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 158. South Korea Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 159. India Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 160. Australia Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Measle Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Measle Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Measle Vaccine Sales by Type (2021-2026) & (K Units) Table 166. SAMEA Measle Vaccine Sales by Type (2027-2032) & (K Units) Table 167. SAMEA Measle Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA Measle Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA Measle Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Measle Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Measle Vaccine Sales by Application (2021-2026) & (K Units) Table 172. SAMEA Measle Vaccine Sales by Application (2027-2032) & (K Units) Table 173. SAMEA Measle Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA Measle Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA Measle Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Measle Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Measle Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Measle Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA Measle Vaccine Sales by Country (2021-2026) & (K Units) Table 180. SAMEA Measle Vaccine Sales by Country (2027-2032) & (K Units) Table 181. SAMEA Measle Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA Measle Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Argentina Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Chile Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Colombia Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Peru Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Israel Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 190. UAE Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Turkey Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Iran Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Egypt Measle Vaccine Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Measle Vaccine Distributors List Table 197. Measle Vaccine Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Measle Vaccine Image Figure 2. Global Measle Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Measle Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inactivated Vaccine Image Figure 5. Attenuated Vaccine Image Figure 6. Global Measle Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Measle Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Scientific Research Image Figure 10. Others Image Figure 11. Global Measle Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Measle Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Measle Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Measle Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Measle Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Measle Vaccine Sales (2021-2032) & (K Units) Figure 17. Global Measle Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Measle Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Measle Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. Europe Measle Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. China Measle Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Measle Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Measle Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. Global Measle Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Measle Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Measle Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Measle Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Measle Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Measle Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Measle Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Measle Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Measle Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Measle Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Measle Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Measle Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Measle Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Measle Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Measle Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Measle Vaccine Sales Share by Type (2021-2032) Figure 41. North America Measle Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Measle Vaccine Sales Share by Application (2021-2032) Figure 43. North America Measle Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Measle Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Measle Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Measle Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Measle Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Measle Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Measle Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Measle Vaccine Sales Share by Country (2021-2032) Figure 51. China Measle Vaccine Revenue Share by Type (2021-2032) Figure 52. China Measle Vaccine Sales Share by Type (2021-2032) Figure 53. China Measle Vaccine Revenue Share by Application (2021-2032) Figure 54. China Measle Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Measle Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Measle Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Measle Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Measle Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Measle Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Measle Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Measle Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Measle Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Measle Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Measle Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Measle Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Measle Vaccine Sales Share by Country (2021-2032) Figure 67. Measle Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Measle Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Attenuated Vaccine
Applications
  • Hospital
  • Scientific Research
  • Others
Companies covered
  • Merck
  • McKesson Medical
  • Biovac

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Measle Vaccine Market by Type
  3. 1.2.1 Global Measle Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inactivated Vaccine
  5. 1.2.3 Attenuated Vaccine
  6. 1.3 Measle Vaccine Market by Application
  7. 1.3.1 Global Measle Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Scientific Research
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Measle Vaccine Market Dynamics
  1. 2.1 Measle Vaccine Industry Trends
  2. 2.2 Measle Vaccine Industry Drivers
  3. 2.3 Measle Vaccine Industry Opportunities and Challenges
  4. 2.4 Measle Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Measle Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Measle Vaccine Revenue by Region
  3. 3.2.1 Global Measle Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Measle Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Measle Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Measle Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Measle Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Measle Vaccine Sales by Region
  9. 3.4.1 Global Measle Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Measle Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Measle Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Measle Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Measle Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Measle Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Measle Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Measle Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Measle Vaccine Sales by Manufacturers
  6. 4.2.1 Global Measle Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Measle Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Measle Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Measle Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Measle Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Measle Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Measle Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Measle Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Measle Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Measle Vaccine Tier 1, Tier 2, and Tier 3
5 Measle Vaccine Market by Type
  1. 5.1 Global Measle Vaccine Revenue by Type
  2. 5.1.1 Global Measle Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Measle Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Measle Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Measle Vaccine Sales by Type
  6. 5.2.1 Global Measle Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Measle Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Measle Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Measle Vaccine Price by Type
6 Measle Vaccine Market by Application
  1. 6.1 Global Measle Vaccine Revenue by Application
  2. 6.1.1 Global Measle Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Measle Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Measle Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Measle Vaccine Sales by Application
  6. 6.2.1 Global Measle Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Measle Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Measle Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Measle Vaccine Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Measle Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Measle Vaccine Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 McKesson Medical
  8. 7.2.1 McKesson Medical Company Information
  9. 7.2.2 McKesson Medical Business Overview
  10. 7.2.3 McKesson Medical Measle Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 McKesson Medical Measle Vaccine Product Portfolio
  12. 7.2.5 McKesson Medical Recent Developments
  13. 7.3 Biovac
  14. 7.3.1 Biovac Company Information
  15. 7.3.2 Biovac Business Overview
  16. 7.3.3 Biovac Measle Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Biovac Measle Vaccine Product Portfolio
  18. 7.3.5 Biovac Recent Developments
8 North America
  1. 8.1 North America Measle Vaccine Market Size by Type
  2. 8.1.1 North America Measle Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Measle Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Measle Vaccine Price by Type (2021-2032)
  5. 8.2 North America Measle Vaccine Market Size by Application
  6. 8.2.1 North America Measle Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Measle Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Measle Vaccine Price by Application (2021-2032)
  9. 8.3 North America Measle Vaccine Market Size by Country
  10. 8.3.1 North America Measle Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Measle Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Measle Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Measle Vaccine Market Size by Type
  2. 9.1.1 Europe Measle Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Measle Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Measle Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Measle Vaccine Market Size by Application
  6. 9.2.1 Europe Measle Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Measle Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Measle Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Measle Vaccine Market Size by Country
  10. 9.3.1 Europe Measle Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Measle Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Measle Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Measle Vaccine Market Size by Type
  2. 10.1.1 China Measle Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Measle Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Measle Vaccine Price by Type (2021-2032)
  5. 10.2 China Measle Vaccine Market Size by Application
  6. 10.2.1 China Measle Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Measle Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Measle Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Measle Vaccine Market Size by Type
  2. 11.1.1 Asia Measle Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Measle Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Measle Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Measle Vaccine Market Size by Application
  6. 11.2.1 Asia Measle Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Measle Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Measle Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Measle Vaccine Market Size by Country
  10. 11.3.1 Asia Measle Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Measle Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Measle Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Measle Vaccine Market Size by Type
  2. 12.1.1 SAMEA Measle Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Measle Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Measle Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Measle Vaccine Market Size by Application
  6. 12.2.1 SAMEA Measle Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Measle Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Measle Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Measle Vaccine Market Size by Country
  10. 12.3.1 SAMEA Measle Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Measle Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Measle Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Measle Vaccine Value Chain Analysis
  2. 13.1.1 Measle Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Measle Vaccine Production Mode & Process
  6. 13.2 Measle Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Measle Vaccine Distributors
  9. 13.2.3 Measle Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst